Drugs / Standard of Care (SOC)
Drug research

Standard of Care (SOC)

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory FailureNCT07615010MiNK TherapeuticsPhase 2Recruiting2027-06Estimated
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaNCT07371650TRAWPhase 2Active not recruiting2026-12Estimated
NAI for Sepsis With Persistent LymphopeniaNCT07578558IBRXPhase 2Not yet recruiting2027-08-03Estimated
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal BurnsNCT02148705MDWDPhase 3Completed2018-06-12Actual
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPPNCT05366855Vanda PharmaceuticalsPhase 3Terminated2024-07-12Actual
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson DiseaseNCT04884815RAREPhase 1, Phase 2Active not recruiting2029-03Estimated

Regulatory dates and decisions

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.